E. coli vaccine manufacturer is looking for financing in agriculture ( 6 - june - 2011 )
Most Canadian cattle producers do not see financial setback to vaccinate their animals to reduce the bacteria E. coli in the manure so it can be up to Ottawa to be worthwhile.
Bioniche Life Sciences, a Belleville, Ontario. company that developed the vaccine is only registered against E. coli O157: H7 in cattle, says that he brought this argument to Ottawa on Wednesday in an appearance before the House of Commons' subcommittee on food safety.
"It seems that Bioniche that most Canadian farmers are willing to give the vaccine, but can not afford to incur the expense of the vaccine without receiving a compensating increase in income," the company said in a statement Thursday.
"At the same time, farmers believe that they receive no immediate or direct benefit to spend money to vaccinate their cattle against E. coli O157. Bioniche is seeking the support of government to provide seed funding to encourage adoption, as E. coli O157 poses a serious risk to human health. "
"This initiative will position Canada as a world leader in food safety, preserve consumer confidence in Canadian agricultural products and strengthen the public health," said Rick Culbert, President of Bioniche Food Safety Division, the company statement .
Bioniche's vaccine, marketed under the name Econiche, have been found in field studies and clinical trials to reduce the colonization of cows by O157 bacteria and reduce the amount of bacteria shed in the manure of cattle, reducing the number of bacteria to which humans may be exposed, the company said.
Bioniche Life Sciences, a Belleville, Ontario. company that developed the vaccine is only registered against E. coli O157: H7 in cattle, says that he brought this argument to Ottawa on Wednesday in an appearance before the House of Commons' subcommittee on food safety.
"It seems that Bioniche that most Canadian farmers are willing to give the vaccine, but can not afford to incur the expense of the vaccine without receiving a compensating increase in income," the company said in a statement Thursday.
"At the same time, farmers believe that they receive no immediate or direct benefit to spend money to vaccinate their cattle against E. coli O157. Bioniche is seeking the support of government to provide seed funding to encourage adoption, as E. coli O157 poses a serious risk to human health. "
"This initiative will position Canada as a world leader in food safety, preserve consumer confidence in Canadian agricultural products and strengthen the public health," said Rick Culbert, President of Bioniche Food Safety Division, the company statement .
Bioniche's vaccine, marketed under the name Econiche, have been found in field studies and clinical trials to reduce the colonization of cows by O157 bacteria and reduce the amount of bacteria shed in the manure of cattle, reducing the number of bacteria to which humans may be exposed, the company said.
0 comments:
Post a Comment